Friday, April 24, 2020 7:39:48 AM
Shareholders are looking for strong management here, to bring this stock to the next level.
One point worth examining further is the issue of dissent in management. Plowing through all the court documents regarding WMB and ETE, there are some really deep signs of problems. Specifically, documents show that board members have actually spoken against CEO Armstrong and expressed concerns about some very strange actions he took regarding the cancellation of the merger with ETE. Board members called Armstrong's actions “unbecoming of an officer of a public corporation.”
I couldn't find filings on the actual legal cost of this fight, but no doubt it is highly expensive. And the judge has indicated multiple times that WMB is not positioned to win this thing.
I would like to see more leadership from the CEO here. Ultimately, shareholders have to hold management accountable and I don't think they are acting in the best interest of the company. Likewise with the poison pill. It goes beyond protecting the company to being overly reactionary.
Recent WMB News
- Williams Announces Quarterly Cash Dividend • Business Wire • 04/30/2024 03:19:00 PM
- Williams to Volunteer at nearly 100 Community Projects Across 17 States • Business Wire • 04/18/2024 03:36:00 PM
- Williams to Report First-Quarter 2024 Financial Results on May 6; Earnings Conference Call and Webcast Scheduled for May 7 • Business Wire • 04/16/2024 08:15:00 PM
- TETRA TECHNOLOGIES, INC. ANNOUNCES APPOINTMENT OF ANGELA D. JOHN TO ITS BOARD OF DIRECTORS • PR Newswire (US) • 03/21/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 09:35:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/06/2024 04:02:55 PM
- Williams Executives to Speak at CERAWeek 2024 • Business Wire • 02/29/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 07:59:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 07:57:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 07:56:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 07:56:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 07:55:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 07:54:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 07:47:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 07:40:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 07:34:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 08:53:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 08:51:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 08:49:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 08:48:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 08:46:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 08:39:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 08:37:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 08:35:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 08:33:27 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM